Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Intézmény

Royal Adelaide Hospital

Adelaide, AusztráliaHonlap

Más néven: RAH

177futó vizsgálat
73lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
Swabs in Screening for HPV (SWISH)
NCT07790601· Forrás
Toboroz
Primary Radiotherapy In MEtastatic Lung Cancer
NCT07135882· 3. fázis· Forrás
Még nem toboroz
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
NCT07861100· 3. fázis· Forrás
Még nem toboroz
Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)
NCT07555587· 1. fázis· Forrás
Toboroz
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· 3. fázis· Forrás
Toboroz
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
NCT07362446· 2. fázis· Forrás
Toboroz
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
NCT07668388· 2. fázis· Forrás
Toboroz
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
NCT07422480· 3. fázis· Forrás
Toboroz
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772· 1/2. fázis· Forrás
Toboroz
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
NCT07469891· 1. fázis· Forrás
Toboroz
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT07455851· 1/2. fázis· Forrás
Toboroz
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302· 3. fázis· Forrás
Toboroz
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
NCT06980480· 3. fázis· Forrás
Toboroz
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT07222761· 3. fázis· Forrás
Toboroz
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
NCT07100730· 3. fázis· Forrás
Toboroz
PRIORITY-CONNECT 2 Trial
NCT06976710· Forrás
Toboroz
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722· 2/3. fázis· Forrás
Toboroz
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
NCT07207811· 3. fázis· Forrás
Toboroz
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
NCT07008118· 1. fázis· Forrás
Toboroz
A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa
NCT06628947· 2. fázis· Forrás
Toboroz
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168· 2. fázis· Forrás
Toboroz
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
NCT06892522· 1/2. fázis· Forrás
Toboroz
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
NCT06979375· 2. fázis· Forrás
Toboroz
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT06902558· 2. fázis· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)
NCT07202078· 2/3. fázis· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
NCT07202052· 2/3. fázis· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)
NCT07202091· 2/3. fázis· Forrás
Toboroz
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
NCT06499285· 3. fázis· Forrás
Toboroz
Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
NCT06825702· 2. fázis· Forrás
Toboroz
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)
NCT07202065· 2/3. fázis· Forrás
Toboroz
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
NCT06510699· 2. fázis· Forrás
Fut, nem toboroz
ASCEND CSP IDE Study
NCT06830746· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933· 2. fázis· Forrás
Toboroz
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
NCT06717347· 3. fázis· Forrás
Toboroz
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
NCT06585774· 3. fázis· Forrás
Fut, nem toboroz
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
NCT06456463· 2. fázis· Forrás
Toboroz
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
NCT06712316· 2/3. fázis· Forrás
Toboroz
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332· 4. fázis· Forrás
Még nem toboroz
Surgery and Reducing Ionizing Radiation of the Unknown Primary
NCT06578871· 2. fázis· Forrás
Toboroz
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
NCT06798896· 2. fázis· Forrás
Toboroz
A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
NCT06701721· 1. fázis· Forrás
Toboroz
A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT06669247· 1/2. fázis· Forrás
Toboroz
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
NCT06465953· 3. fázis· Forrás
Fut, nem toboroz
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247· 3. fázis· Forrás
Fut, nem toboroz
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
NCT06492837· 2. fázis· Forrás
Toboroz
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis
NCT07612280· 1/2. fázis· Forrás
Toboroz
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
NCT06561048· 3. fázis· Forrás
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Forrás
Toboroz
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
NCT06379789· 1/2. fázis· Forrás
Toboroz
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
NCT06384963· Forrás

Showing 50 of 177.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
Transscleral Selective Laser Trabeculoplasty Project
NCT06833060· Forrás
Lezárult
FOCALFLEX (CE Mark) Study
NCT06271967· Forrás
Leállították
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
NCT06488911· 3. fázis· Forrás
Lezárult
VOLT-AF IDE Clinical Study
NCT06223789· Forrás
Lezárult
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
NCT06016088· 1/2. fázis· Forrás
Visszavonták
A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
NCT05927012· 2. fázis· Forrás
Lezárult
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
NCT06077864· 3. fázis· Forrás
Lezárult
A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480· 2. fázis· Forrás
Lezárult
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
NCT05583552· 2. fázis· Forrás
Lezárult
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957· 3. fázis· Forrás
Lezárult
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070· 3. fázis· Forrás
Lezárult
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580· 2. fázis· Forrás
Lezárult
TESTING -ON Post-Trial ObservatioNal Cohort Study
NCT05434325· Forrás
Lezárult
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
NCT05282953· 1/2. fázis· Forrás
Lezárult
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)
NCT05508867· 2. fázis· Forrás
Lezárult
A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review
NCT05444972· Forrás
Lezárult
A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma
NCT05243342· 1. fázis· Forrás
Lezárult
Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
NCT05203224· 2. fázis· Forrás
Lezárult
Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
NCT05130970· 2. fázis· Forrás
Lezárult
An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)
NCT05223920· 2. fázis· Forrás
Lezárult
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT05199337· 1/2. fázis· Forrás
Leállították
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)
NCT04968184· 3. fázis· Forrás
Lezárult
Does Eliminating Coffee Avoid Fibrillation?
NCT05121519· Forrás
Lezárult
Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT05016882· 2. fázis· Forrás
Lezárult
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
NCT05021835· 3. fázis· Forrás
Leállították
Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
NCT04778397· 3. fázis· Forrás
Lezárult
Comprehensive Geriatric Assessment for Frail Older People With Chronic Kidney Disease - The GOAL Trial
NCT04538157· Forrás
Lezárult
A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO)
NCT04438304· 2. fázis· Forrás
Lezárult
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
NCT04750226· 3. fázis· Forrás
Lezárult
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
NCT03969953· 3. fázis· Forrás
Lezárult
Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A
NCT04323098· 3. fázis· Forrás
Lezárult
Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy
NCT04576689· 2. fázis· Forrás
Lezárult
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
NCT04428151· 2. fázis· Forrás
Leállították
Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion
NCT04454788· 3. fázis· Forrás
Leállították
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
NCT04316013· 3. fázis· Forrás
Leállították
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
NCT04365868· 2/3. fázis· Forrás
Lezárult
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
NCT04379050· 3. fázis· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT04255433· 3. fázis· Forrás
Lezárult
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab
NCT04282018· 1/2. fázis· Forrás
Lezárult
A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
NCT04102020· 3. fázis· Forrás
Lezárult
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)
NCT04199104· 3. fázis· Forrás
Lezárult
A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)
NCT04138277· 3. fázis· Forrás
Toboroz
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
NCT04075084· Forrás
Lezárult
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
NCT03876457· Forrás
Lezárult
A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases
NCT03497767· 2. fázis· Forrás
Lezárult
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
NCT03904693· 3. fázis· Forrás
Lezárult
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
NCT03872401· 3. fázis· Forrás
Lezárult
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
NCT03867084· 3. fázis· Forrás
Leállították
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
NCT03646123· 2. fázis· Forrás
Leállították
A Phase 1 Study of [225Ac]-FPI-1434 Injection
NCT03746431· 1. fázis· Forrás

Showing 50 of 73.

Vizsgálati helyszínek

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Intézményadatok: ROR 00carf720 (CC0-1.0)Frissítve: 2026. nov. 10.

Építés alatt, nem éles – Royal Adelaide Hospital: vizsgálatok és kutatócsoportok – Frontlight Research